NCT01081158: Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) |
|
|
| Completed | 1 | 41 | RoW | Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron), narlaprevir, PegIntron, Drug: SCH 900518 Biologic: Peginterferon alfa-2b, Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron), narlaprevir, norvir, PegIntron, Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron) | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 08/08 | 08/08 | | |
